Your browser doesn't support javascript.
loading
Corrigendum: Clinical value of metagenomic next-generation sequencing by Illumina and Nanopore for the detection of pathogens in bronchoalveolar lavage fluid in suspected community-acquired pneumonia patients.
Zhang, Jing; Gao, Lin; Zhu, Chi; Jin, Jiajia; Song, Chao; Dong, Hang; Li, Zhenzhong; Wang, Zheng; Chen, Yubao; Yang, Zhenhua; Tan, Yan; Wang, Li.
Affiliation
  • Zhang J; Department of Respiratory and Critical Care Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Gao L; Department of Respiratory and Critical Care Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Zhu C; State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing, China.
  • Jin J; Department of Respiratory and Critical Care Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Song C; State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing, China.
  • Dong H; State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing, China.
  • Li Z; State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing, China.
  • Wang Z; Department of Respiratory and Critical Care Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Chen Y; Department of Respiratory and Critical Care Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Yang Z; Department of Respiratory and Critical Care Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Tan Y; Department of Respiratory and Critical Care Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Wang L; Department of Respiratory and Critical Care Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Front Cell Infect Microbiol ; 14: 1468511, 2024.
Article de En | MEDLINE | ID: mdl-39149418

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Front Cell Infect Microbiol / Front. cell. infect. microbiol / Frontiers in cellular and infection microbiology Année: 2024 Type de document: Article Pays d'affiliation: Chine Pays de publication: Suisse

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Front Cell Infect Microbiol / Front. cell. infect. microbiol / Frontiers in cellular and infection microbiology Année: 2024 Type de document: Article Pays d'affiliation: Chine Pays de publication: Suisse